Abstract During the last two decades, radionuclide myocardial perfusion scintigraphy (MPS) has become established as the main noninvasive cardiac imaging technique for the assessment of ischaemic heart disease (IHD). Despite a growing number of alternative imaging techniques, MPS still remains the most widely used technique, with a wealth of literature supporting its usefulness in assessing IHD and predicting prognosis. The technique itself has evolved, making it more reliable and robust, with additional ventricular functional information that further defines the prognosis […]
